Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:145076.
doi: 10.1155/2013/145076. Epub 2013 Jul 28.

Neurofibromatosis type 1 with bladder involvement

Affiliations

Neurofibromatosis type 1 with bladder involvement

Iyimser Ure et al. Case Rep Urol. 2013.

Abstract

Neurofibromatosis type 1 is an autosomal dominant transmitted disease with various clinical manifestations. The bladder is the most commonly affected organ in the genitourinary system. The malignant transformation of the disease is rare, and unlike malign tumors, the treatment option for benign disease is usually conservative. The size and localization of the mass determine the symptoms, most of which are usually not specific. In this paper, we aim to present a 15-year-old patient with neurofibromatosis type 1 with bladder involvement. The clinical presentation and treatment options of this disease are discussed in the light of the literature.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intravenous pyelography of the patient before operation. A large filling defect can be seen in the bladder (a). A CT image showing a heterogeneous, contrast enhancing mass at the posterior wall of the bladder extending through the ureteral orifices (b). Five years after operation. CT image shows no radiological evidence of the disease (c).
Figure 2
Figure 2
Gross specimen of partial cystectomy showing a diffuse infiltrative mass in the wall of the bladder (a). Light microscopy showed a moderately cellular lesion composed of spindle cells with poorly defined, palely eosinophilic cytoplasm and tapering nuclei, admixed with mononuclear inflammatory cells H&E ×100 (b). Immunostaining showing diffuse and strong positivity of the lesion with S-100 protein, streptavidine biotin peroxidase ×100 (c).

References

    1. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genetics in Medicine. 2010;12(1):1–11. - PubMed
    1. Scheithauer BW, Santi M, Richter ER, Belman B, Rushing EJ. Diffuse ganglioneuromatosis and plexiform neurofibroma of the urinary bladder: report of a pediatric example and literature review. Human Pathology. 2008;39(11):1708–1712. - PubMed
    1. Chakravarti A, Jones MA, Simon J. Neurofibromatosis involving the urinary bladder. International Journal of Urology. 2001;8(11):645–647. - PubMed
    1. Karatzoglou P, Karagiannidis A, Kountouras J, et al. Von Recklinghausen’s disease associated with malignant peripheral nerve sheath tumor presenting with constipation and urinary retention: a case report and review of the literature. Anticancer Research. 2008;28(5 B):3107–3113. - PubMed
    1. Hintsa A, Lindell O, Heikkilä P. Neurofibromatosis of the bladder. Scandinavian Journal of Urology and Nephrology. 1996;30(6):497–499. - PubMed

LinkOut - more resources